| Literature DB >> 27087556 |
Jongkit Masiri1, Lora Benoit2, Madhu Katepalli1, Mahzad Meshgi1, David Cox1, Cesar Nadala1, Shao-Lei Sung3, Mansour Samadpour1,2.
Abstract
Gluten derived from wheat and related Triticeae can induce gluten sensitivity as well as celiac disease. Consequently, gluten content in foods labeled "gluten-free" is regulated. Determination of potential contamination in such foods is achieved using immunoassays based on monoclonal antibodies (mAbs) that recognize specific epitopes present in gluten. However, food-processing measures can affect epitope recognition. In particular, preparation of wheat protein isolate through deamidation of glutamine residues significantly limits the ability of commercial gluten testing kits in their ability to recognize gluten. Adding to this concern, evidence suggests that deamidated gluten imparts more pathogenic potential in celiac disease than native gluten. To address the heightened need for antibody-based tools that can recognize deamidated gluten, we have generated a novel mAb, 2B9, and subsequently developed it as a rapid lateral flow immunoassay. Herein, we report the ability of the 2B9-based lateral flow device (LFD) to detect gluten from wheat, barley, and rye and deamidated gluten down to 2 ppm in food as well as its performance in food testing.Entities:
Keywords: LFD; celiac disease; deamidation; gliadin; gluten; mAb; prolamins; wheat protein isolate
Mesh:
Substances:
Year: 2016 PMID: 27087556 DOI: 10.1021/acs.jafc.5b06085
Source DB: PubMed Journal: J Agric Food Chem ISSN: 0021-8561 Impact factor: 5.279